Transitional cell carcinoma of the ureter and renal pelvis (Q35192410)

7 August 2017

1 reference

title

Transitional cell carcinoma of the ureter and renal pelvis (English)

1 reference

renal pelvis transitional cell carcinoma

7 August 2017

0 references

author name string

Ziya Kirkali

series ordinal

1

1 reference

PubMed ID

12900009

7 August 2017

Emre Tuzel

series ordinal

2

1 reference

7 August 2017

1 August 2003

1 reference

Critical Reviews in Oncology Hematology

7 August 2017

1 reference

7 August 2017

47

1 reference

7 August 2017

2

1 reference

7 August 2017

155-169

1 reference

Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell tumors of the renal pelvis and ureter associated with capillarosclerosis indicating analgesic abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Unusual clinical presentation of upper urothelial carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Extracolonic cancer in hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Cytogenetic investigation of transitional cell carcinomas of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Cytogenetic analysis of upper urinary tract transitional cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Comparative genomic hybridization analysis of transitional cell carcinomas of the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Risk factors for the development of bladder cancer after upper tract urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Tumor grade and stage as prognostic variables in upper tract urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Urothelial tumours of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

A comparative study of transitional cell tumors of the bladder and upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Clinicopathological study of upper urinary tract tumors associated with bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper tract urothelial tumor after transurethral resection for bladder tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Synchronous and metachronous transitional cell carcinoma of the urinary tract: prevalence, incidence, and radiographic detection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper urinary tract transitional cell cancer after radical cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper tract tumours following cystectomy for bladder cancer. Is routine intravenous urography worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Nephroureterectomy after radical cystectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Development of upper tract carcinoma after cystectomy for bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell carcinoma of the pelvicalices and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Endoluminal sonographic evaluation of ureteral and renal pelvic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Computed tomography of transitional-cell carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Computerized tomography for detection and staging of localized and pathologically defined upper tract urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Computed tomography for detection and staging of transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional carcinoma of the upper urinary tract: a histological and cytopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteroscopic management of patients with upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Improved technique for retrograde brushing in diagnosis of urothelial tumors of upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Fluoroscopically guided retrograde brush biopsy in the diagnosis of transitional cell carcinoma of the upper urinary tract: results in 45 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Renal Brush Biopsy: Survey of Indications, Techniques and Results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteroscopic biopsy in the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteroscopic cytologic diagnosis of upper tract lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Utility of the Bard BTA test in detecting upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Renal pelvic carcinoma: morphological correlates of metastatic behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The prognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Intraductal tumor involvement and renal parenchymal invasion of transitional cell carcinoma in the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Histopathological features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Tumors of the upper urinary tract: 10 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Immunohistological detection of T antigen and ABH blood group antigens in upper urinary tract tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Blood groups and transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

E-cadherin expression in upper-urinary-tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

When is partial ureterectomy acceptable for transitional-cell carcinoma of the ureter?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Conservative surgery for transitional cell carcinoma of the renal pelvis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Endourologic management of upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The long-term outcome after laparoscopic nephroureterectomy: a comparison with open nephroureterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Retroperitoneoscopic nephroureterectomy for renal pelvic tumors with a single iliac incision

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Laparoscopic radical nephroureterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Laparoscopic nephroureterectomy. A new standard for the surgical management of upper tract transitional cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Hand-assisted laparoscopic renal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Retroperitoneal laparoscopic nephroureterectomy and management options for the distal ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Prospective comparison between hand-assisted laparoscopic and open surgical nephroureterectomy for urothelial cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Upper-tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteroscopic surgery for upper tract transitional-cell carcinoma: complications and management

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Transitional-cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteroscopic treatment of urothelial carcinoma of the ureter and renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Conservative treatment of upper urinary tract tumors with Nd:YAG laser

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Primary percutaneous approach to upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

13-year experience with percutaneous management of upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Definitive tumor resection and percutaneous bacille Calmette-Guérin for management of renal pelvic transitional cell carcinoma in solitary kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900079-9

7 January 2021

10.1016/S1040-8428(03)00079-9

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12900009